arrow
J

Jean-Michel Halimi

centre hospitalier universitaire de tours
H指数:44
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of renin-angiotensin system inhibitors discontinuation in advanced chronic kidney disease: a target trial emulation

在进展性慢性肾病中肾素-血管紧张素系统抑制剂停用的影响:一项目标试验模拟

2026-09-040
OAAI
Design and baseline characteristics of the ZENITH high proteinuria trial testing zibotentan/dapagliflozin efficacy on CKD progression

ZENITH高蛋白尿试验的设计和基线特征:评估zibotentan/dapagliflozin对CKD进展有效性的研究

2026-08-040
OAAI
Impact of high intensity physical activity compared to routine counseling on renal function decline in patients with type 2 diabetes at high risk for kidney disease-the ACTIDIANE randomized controlled trial

高强度身体活动与常规咨询对高风险肾脏疾病2型糖尿病患者肾功能下降的影响——ACTIDIANE随机对照试验

2026-07-010
OAAI
Renal Histology Findings in Malignant Hypertension, a Systematic Review

恶性高血压的肾脏组织学发现:一项系统综述

2026-01-012
PRE
The personalized approach to rituximab treatment in membranous nephropathy: a multi-center randomized controlled trial

膜性肾病利妥昔单抗治疗的个体化方法:一项多中心随机对照试验

2025-11-140
OAAI
Testosterone therapy is associated with reduced risk of acute kidney injury, kidney failure with renal replacement therapy, and cardiovascular events in men with diabetes and hypogonadism

睾酮疗法与糖尿病伴性腺功能减退男性的急性肾损伤、需行肾脏替代治疗的肾衰竭以及心血管事件风险降低相关。

2025-10-030
OA
Walking autonomy in chronic dialysis patients: insights from a nationwide registry and focus group analysis

慢性透析患者的步行自主性:全国注册登记和焦点小组分析的研究启示

2025-08-011
OAAI
Anti-ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune-Mediated TTP

抗ADAMTS13抗体轨迹与免疫介导性TTP中ADAMTS13恢复相关

2025-07-150
OAAI
Expert perspectives on incorporating glucagon-like peptide-1 receptor agonist in diabetes and chronic kidney disease: challenges and opportunities

专家视角:在糖尿病和慢性肾脏病中纳入胰高血糖素样肽-1受体激动剂的挑战与机遇

2025-07-010
OAAI